Cargando…

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade

BACKGROUND: During the last decade, neoadjuvant chemotherapy (NACT) of early breast cancer (EBC) evolved from a therapy intended to enable operability to a standard treatment option aiming for increasing cure rates equivalent to adjuvant chemotherapy (ACT). In parallel, improvements in the quality c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hennigs, A., Riedel, F., Marmé, F., Sinn, P., Lindel, K., Gondos, A., Smetanay, K., Golatta, M., Sohn, C., Schuetz, F., Heil, J., Schneeweiss, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090013/ https://www.ncbi.nlm.nih.gov/pubmed/27744486 http://dx.doi.org/10.1007/s10549-016-4016-4

Ejemplares similares

Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study
por: Hennigs, André, et al.
Publicado: (2016)

Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?
por: Schaefgen, Benedikt, et al.
Publicado: (2021)

Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index
por: Michel, Laura L., et al.
Publicado: (2019)

Conventional specimen radiography in breast-conserving therapy: a useful tool for intraoperative margin assessment after neoadjuvant therapy?
por: Schäfgen, Benedikt, et al.
Publicado: (2023)

Exam preparatory course for the 2nd part of the German medical examination in obstetrics and gynecology – a potential tool for the recruitment of new residents during the occupational decision process before the practical year?
por: Riedel, Fabian, et al.
Publicado: (2019)

Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer
por: Cuk, Katarina, et al.
Publicado: (2013)

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial
por: von Au, Alexandra, et al.
Publicado: (2016)

Surgeon’s preference of subcutaneous tissue resection: most important factor for short-term complications in subcutaneous implant placement after mastectomy—results of a cohort study
por: Pfob, André, et al.
Publicado: (2020)

Impact of age on indication for chemotherapy in early breast cancer patients: results from 104 German institutions from 2008 to 2017
por: Hoffmann, Ann Sophie, et al.
Publicado: (2023)

Long-Term Patient Satisfaction and Quality of Life After Breast-Conserving Therapy: A Prospective Study Using the BREAST-Q
por: Stolpner, Ilona, et al.
Publicado: (2021)

Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008–2017
por: Riedel, Fabian, et al.
Publicado: (2021)

Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?
por: Richter, Hannah, et al.
Publicado: (2018)

First proof-of-concept evaluation of the FUSION-X-US-II prototype for the performance of automated breast ultrasound in healthy volunteers
por: Schaefgen, Benedikt, et al.
Publicado: (2021)

Laparoscopic complete mesocolic excisions for colonic cancer in the last decade: Five-year survival in a single centre
por: Storli, Kristian Eeg, et al.
Publicado: (2017)

Analyzing non-sentinel axillary metastases in patients with T3–T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy
por: Riedel, Fabian, et al.
Publicado: (2020)

Adjuvant Radiation Therapy for Male Breast Cancer—A Rare Indication?
por: Forster, Tobias, et al.
Publicado: (2020)

Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer
por: von Au, Alexandra, et al.
Publicado: (2022)

RESPONDER – diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial
por: Heil, Joerg, et al.
Publicado: (2018)

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy
por: Pixberg, C., et al.
Publicado: (2022)

Parity improves anti-tumor immunity in breast cancer patients
por: Krause, Anna-Lena, et al.
Publicado: (2017)

Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study
por: Krajnak, S., et al.
Publicado: (2020)

ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
por: Monk, Bradley J, et al.
Publicado: (2021)

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
por: Walter, Vincent, et al.
Publicado: (2020)

Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence
por: Cheng, Jie, et al.
Publicado: (2017)

Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis
por: Winarto, Hariyono, et al.
Publicado: (2022)

Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer
por: Yu, Y. F., et al.
Publicado: (2017)

Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
por: Cazzaniga, M. E., et al.
Publicado: (2021)

Terahertz Radiation: Last Decade Publications
por: Cherkassky, V S, et al.
Publicado: (2002)

Language assessment and treatment in the last decade
por: Mansur, Leticia, et al.
Publicado: (2014)

Second breast conserving therapy after ipsilateral breast tumor recurrence – a 10-year experience of re-irradiation
por: Forster, Tobias, et al.
Publicado: (2019)

Laryngopharyngeal Reflux: The Last Decade
por: Karkos, Petros D., et al.
Publicado: (2022)

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
por: Ohno, S., et al.
Publicado: (2013)

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
por: Yndigegn, Troels, et al.
Publicado: (2022)

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
por: Cazzaniga, M. E., et al.
Publicado: (2016)

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience
por: Vriens, Ingeborg J. H., et al.
Publicado: (2020)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy
por: Pedersini, Rebecca, et al.
Publicado: (2023)

Model Thermohaline Trends in the Mediterranean Sea during the Last Years: A Change with Respect to the Last Decades?
por: Soto-Navarro, F. Javier, et al.
Publicado: (2012)

Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals
por: Cao, Xue, et al.
Publicado: (2018)

Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
por: Chen, Bihong T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eboaks7iprb0850p3jqmb732v6